The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Progesterone and Breast Cancer
Open accessAbstract
Synthetic progestogens (progestins) have been linked to increased breast cancer risk; however, the role of endogenous progesterone in breast physiology and carcinogenesis is less clearly defined. Mechanistic studies using cell culture, tissue culture, and preclinical models implicate progesterone in breast carcinogenesis. In contrast, limited epidemiologic data generally do not show an association of circulating progesterone levels with risk, and it is unclear whether this reflects methodologic limitations or a truly null relationship. Challenges related to defining the role of progesterone in breast physiology and neoplasia include: complex interactions with estrogens and other hormones (eg, androgens, prolactin, etc.), accounting for timing of blood collections for hormone measurements among cycling women, and limitations of assays to measure progesterone metabolites in blood and progesterone receptor isotypes (PRs) in tissues. Separating the individual effects of estrogens and progesterone is further complicated by the partial dependence of PR transcription on estrogen receptor (ER)α-mediated transcriptional events; indeed, interpreting the integrated interaction of the hormones may be more essential than isolating independent effects. Further, many of the actions of both estrogens and progesterone, particularly in “normal” breast tissues, are driven by paracrine mechanisms in which ligand binding to receptor-positive cells evokes secretion of factors that influence cell division of neighboring receptor-negative cells. Accordingly, blood and tissue levels may differ, and the latter are challenging to measure. Given conflicting data related to the potential role of progesterone in breast cancer etiology and interest in blocking progesterone action to prevent or treat breast cancer, we provide a review of the evidence that links progesterone to breast cancer risk and suggest future directions for filling current gaps in our knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
kConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
Control of mammary stem cell function by steroid hormone signalling
Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., et al. (2010) · Nature · doi:10.1038/nature09027 · Cited by 693
Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9523-x · Cited by 693
Yang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., Gaudet, M., Schmidt, M. K., Broeks, A., Cox, A., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq526 · Cited by 691
Self-citationProgesterone induces adult mammary stem cell expansion
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D., & Khokha, R. (2010) · Nature · doi:10.1038/nature09091 · Cited by 689
Westphal, U. F. (1963) · doi:10.21236/ad0423987 · Cited by 674
Progesterone receptor modulates ERα action in breast cancer
Mohammed, H., Russell, I. A., Stark, R., Rueda, O. M., Hickey, T. E., Tarulli, G. A., Serandour, A. A., Birrell, S. N., Bruna, A., Saadi, A., et al. (2015) · Nature · doi:10.1038/nature14583 · Cited by 659
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650
Contemporary Hormonal Contraception and the Risk of Breast Cancer
Mørch, L. S., Skovlund, C. W., Hannaford, P. C., Iversen, L., Fielding, S., & Lidegaard, Ø. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700732 · Cited by 641
Dissociation between steroid receptor expression and cell proliferation in the human breast.
Clarke, R. B., Howell, A., Potten, C. S., & Anderson, E. J. (1997) · PubMed · Cited by 625
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Mammary stem cells and the differentiation hierarchy: current status and perspectives
Visvader, J. E., & Stingl, J. (2014) · Genes & Development · doi:10.1101/gad.242511.114 · Cited by 562
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J., & Conneely, O. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732707100 · Cited by 547
Oral Contraceptives and the Risk of Breast Cancer
Marchbanks, P. A., McDonald, J. A., Wilson, H. G., Folger, S. G., Mandel, M. G., Daling, J. R., Bernstein, L., Malone, K. E., Ursin, G., Strom, B. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013202 · Cited by 532
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Missmer, S. A., Eliassen, A. H., Barbieri, R. L., & Hankinson, S. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh336 · Cited by 516
Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling
Brisken, C., Heineman, A., Chavarria, T., Elenbaas, B., Tan, J., Dey, S. K., McMahon, J. A., McMahon, A. P., & Weinberg, R. A. (2000) · Genes & Development · doi:10.1101/gad.14.6.650 · Cited by 489
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., & Karin, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00599-2 · Cited by 482
A paracrine role for the epithelial progesterone receptor in mammary gland development
Brisken, C., Park, S., Vass, T., Lydon, J. P., O’Malley, B. W., & Weinberg, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5076 · Cited by 479
Mallepell, S., Krust, A., Chambon, P., & Brisken, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510974103 · Cited by 432
Oral contraceptives and the risk of breast cancer*
(2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200304000-00031 · Cited by 431
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
Self-citationFournier, A., Berrino, F., Riboli, E., Avenel, V., & Clavel‐Chapelon, F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20710 · Cited by 403
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Proia, T. A., Keller, P. J., Gupta, P. B., Klebba, I., Jones, A. D., Sedic, M., Gilmore, H., Tung, N., Naber, S. P., Schnitt, S., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.007 · Cited by 393
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Luo, J., Yang, Z., Ma, Y., Yue, Z., Lin, H., Qu, G., Huang, J., Dai, W., Li, C., Zheng, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4076 · Cited by 370
Randolph, J. F., Zheng, H., Sowers, M. R., Crandall, C., Crawford, S., Gold, E. B., & Vuga, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1746 · Cited by 369
Anderson, G. L., Chlebowski, R. T., Aragaki, A. K., Kuller, L. H., Manson, J. E., Gass, M., Bluhm, E., Connelly, S., Hubbell, F. A., Lane, D., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70075-x · Cited by 364
Progesterone receptor membrane component 1: An integrative review
Cahill, M. A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.02.002 · Cited by 358
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis
Pierobon, M., & Frankenfeld, C. L. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2339-3 · Cited by 357
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
Van Keymeulen, A., Lee, M. Y., Ousset, M., Brohée, S., Rorive, S., Giraddi, R. R., Wuidart, A., Bouvencourt, G., Dubois, C., Salmon, I., et al. (2015) · Nature · doi:10.1038/nature14665 · Cited by 354
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
Eirew, P., Stingl, J., Raouf, A., Turashvili, G., Aparicio, S., Emerman, J. T., & Eaves, C. J. (2008) · Nature Medicine · doi:10.1038/nm.1791 · Cited by 339
Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
Tung, L., Mohamed, M. K., Hoeffler, J. P., Takimoto, G. S., & Horwitz, K. B. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8123133 · Cited by 324
The effect of age and menstrual cycle upon proliferative activity of the normal human breast
Potten, C., Watson, R., Williams, G., Tickle, S., Roberts, S., Harris, M., & Howell, A. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.185 · Cited by 311
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Nolan, E., Vaillant, F., Branstetter, D., Pal, B., Giner, G., Whitehead, L., Lok, S. W., Mann, G. B., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Rohrbach, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4118 · Cited by 309
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
Beleut, M., Rajaram, R. D., Caikovski, M., Ayyanan, A., Germano, D., Choi, Y., Schneider, P., & Brisken, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915148107 · Cited by 307
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women
Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Castiel, I., Chaussade, V., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.02.004 · Cited by 296
Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey, T. E., Robinson, J. L. L., Carroll, J. S., & Tilley, W. D. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1107 · Cited by 289
Thomas, H., Key, T., Allen, D., Moore, J., Dowsett, M., Fentiman, I., & Wang, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.398 · Cited by 289
A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle
Longacre, T. A., & Bartow, S. A. (1986) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198606000-00003 · Cited by 286
Conneely, O. M., Mulac-Jericevic, B., & Lydon, J. P. (2003) · Steroids · doi:10.1016/s0039-128x(03)00126-0 · Cited by 277
Gusterson, B. A., & Stein, T. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.03.013 · Cited by 277
Reproductive tissue selective actions of progesterone receptors
Mulac-Jericevic, B., & Conneely, O. M. (2004) · Reproduction · doi:10.1530/rep.1.00189 · Cited by 276
Feng, Y., Manka, D., Wagner, K.-U., & Khan, S. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706933104 · Cited by 274
How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M., & Sherman, M. E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju165 · Cited by 265
Self-citationProgesterone signalling in breast cancer: a neglected hormone coming into the limelight
Brisken, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3518 · Cited by 255
Howard, B. A., & Gusterson, B. A. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026487120779 · Cited by 245
Defining the cellular precursors to human breast cancer
Keller, P. J., Arendt, L. M., Skibinski, A., Logvinenko, T., Klebba, I., Dong, S., Smith, A. E., Prat, A., Perou, C. M., Gilmore, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017626108 · Cited by 233
All progestins are not created equal
Stanczyk, F. Z. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.003 · Cited by 226
Progesterone receptors, their isoforms and progesterone regulated transcription
Jacobsen, B. M., & Horwitz, K. B. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.016 · Cited by 226
Boonyaratanakornkit, V., McGowan, E., Sherman, L., Mancini, M. A., Cheskis, B. J., & Edwards, D. P. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0337 · Cited by 222
HORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
Cunha, G. R., Young, P., Hom, Y. K., Cooke, P. S., Taylor, J. A., & Lubahn, D. B. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026303630843 · Cited by 220
Stahlberg, C., Pedersen, A. T., Lynge, E., Andersen, Z. J., Keiding, N., Hundrup, Y. A., Obel, E. B., & Ottesen, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20016 · Cited by 218
Reproductive Hormones and the Menopause Transition
Santoro, N., & Randolph, J. F. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.05.004 · Cited by 217
Development of the Human Breast
Lteif, A., & Javed, A. (2013) · Seminars in Plastic Surgery · doi:10.1055/s-0033-1343989 · Cited by 215
Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast
Tanos, T., Sflomos, G., Echeverria, P. C., Ayyanan, A., Gutierrez, M., Delaloye, J.-F., Raffoul, W., Fiche, M., Dougall, W., Schneider, P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005654 · Cited by 211
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.
Going, J. J., Anderson, T. J., Battersby, S., & Macintyre, C. C. A. (1988) · Europe PMC (PubMed Central) · Cited by 208
Shyamala, G., Yang, X., Silberstein, G., Barcellos-Hoff, M. H., & Dale, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.696 · Cited by 203
Phipps, A. I., Chlebowski, R. T., Prentice, R., McTiernan, A., Stefanick, M. L., Wactawski-Wende, J., Kuller, L. H., Adams-Campbell, L. L., Lane, D., Vitolins, M., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0974 · Cited by 199
Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland
Soini, T., Hurskainen, R., Grénman, S., Mäenpää, J., Paavonen, J., & Pukkala, E. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000356 · Cited by 197
Peluso, J. J., Romak, J., & Liu, X. (2008) · Endocrinology · doi:10.1210/en.2007-1050 · Cited by 195
Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α
Mueller, S. O., Clark, J. A., Myers, P. H., & Korach, K. S. (2002) · Endocrinology · doi:10.1210/endo.143.6.8836 · Cited by 195
Kumle, M. H., Weiderpass, E., Braaten, T., Persson, I. R., Adami, H., & Lund, E. (2002) · PubMed · Cited by 195
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche
Chakrabarti, R., Celià-Terrassa, T., Kumar, S., Hang, X., Wei, Y., Choudhury, A., Hwang, J., Peng, J., Nixon, B., Grady, J. J., et al. (2018) · Science · doi:10.1126/science.aan4153 · Cited by 195
The biology of progesterone receptor in the normal mammary gland and in breast cancer
Obr, A. E., & Edwards, D. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.030 · Cited by 189
GOMPEL, A., MALET, C., SPRITZER, P., LALARDRIE, J.-P., KUTTENN, F., & MAUVAIS-JARVIS, P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1174 · Cited by 179
Dressing, G. E., Goldberg, J. E., Charles, N. J., Schwertfeger, K. L., & Lange, C. A. (2011) · Steroids · doi:10.1016/j.steroids.2010.09.006 · Cited by 178
Rohe, H. J., Ahmed, I. S., Twist, K. E., & Craven, R. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.006 · Cited by 177
RANKL/RANK control Brca1 mutation-driven mammary tumors
Sigl, V., Owusu-Boaitey, K., Joshi, P. A., Kavirayani, A., Wirnsberger, G., Novatchkova, M., Kozieradzki, I., Schramek, D., Edokobi, N., Hersl, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.69 · Cited by 175
Breast cancer risk with postmenopausal hormonal treatment
Collins, J. A., Blake, J. M., & Crosignani, P. G. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi028 · Cited by 172
A prospective study of endogenous hormones and breast cancer.
Kj, H., Aj, A., Tl, B., Longcope, C., Gb, G., & Comstock, G. W. (1994) · PubMed · Cited by 170
Dimitrakakis, C., & Bondy, C. (2009) · Breast Cancer Research · doi:10.1186/bcr2413 · Cited by 167
Brinton, L. A., Cook, M. B., McCormack, V., Johnson, K. C., Olsson, H., Casagrande, J. T., Cooke, R., Falk, R. T., Gapstur, S. M., Gaudet, M. M., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt465 · Cited by 164
Ismail, P. M., Li, J., DeMayo, F. J., O’Malley, B. W., & Lydon, J. P. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0169 · Cited by 163
Seagroves, T. N., Lydon, J. P., Hovey, R. C., Vonderhaar, B. K., & Rosen, J. M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.3.0434 · Cited by 163
Thomas, P., & Pang, Y. (2012) · Neuroendocrinology · doi:10.1159/000339822 · Cited by 161
Zhang, X., Chiang, H.-C., Wang, Y., Zhang, C., Smith, S., Zhao, X., Nair, S. J., Michalek, J., Jatoi, I., Lautner, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15908 · Cited by 158
Faivre, E. J., Daniel, A. R., Hillard, C. J., & Lange, C. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0437 · Cited by 156
Singhal, H., Greene, M. E., Tarulli, G. A., Zarnke, A. L., Bourgo, R. J., Lainé, M., Chang, Y.-F., Ma, S., Dembo, A. G., Raj, G. V., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501924 · Cited by 156
Breast cancer and hormonal contraceptives: further results
Calle, E. E., Heath, C. W., Miracle-McMahill, H. L., Coates, R., Liff, J., Franceschi, S., Talamini, R., Chantarakul, N., Koetsawang, S., Rachawat, D., et al. (1996) · Contraception · doi:10.1016/s0010-7824(15)30002-0 · Cited by 155
Skildum, A. J., Faivre, E. J., & Lange, C. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0306 · Cited by 153
Sedic, M., Skibinski, A., Brown, N. E., Gallardo, M., Mulligan, P., Martínez, P., Keller, P. J., Glover, E., Richardson, A. L., Cowan, J. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8505 · Cited by 152
Chang, K., Lee, T. T. Y., Linares‐Cruz, G., Fournier, S., & Lignieres, B. D. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57482-2 · Cited by 145
Daniel, A. R., Gaviglio, A. L., Knutson, T. P., Ostrander, J. H., D’Assoro, A. B., Ravindranathan, P., Peng, Y. S., Raj, G. V., Yee, D., & Lange, C. A. (2014) · Oncogene · doi:10.1038/onc.2013.579 · Cited by 145
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
Eliassen, A. H., & Hankinson, S. E. (2008) · PubMed · Cited by 141
Fernandez‐Valdivia, R., Mukherjee, A., Yan, Y., Li, J., Paquet, M., DeMayo, F. J., & Lydon, J. P. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.01.019 · Cited by 140
González‐Suárez, E., Branstetter, D. G., Armstrong, A. P., Dinh, H., Blumberg, H., & Dougall, W. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01298-06 · Cited by 140
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Widschwendter, M., Rosenthal, A. N., Philpott, S., Rizzuto, I., Fraser, L. S. M., Hayward, J. D., Intermaggio, M. P., Edlund, C. K., Ramus, S. J., Gayther, S. A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70448-0 · Cited by 137
Endogenous sex hormones and subsequent breast cancer in premenopausal women
Micheli, A., Muti, P. C., Secreto, G., Krogh, V., Meneghini, E., Venturelli, E., Sieri, S., Pala, V. M., & Berrino, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.20403 · Cited by 135
Graham, J. D., Mote, P. A., Salagame, U., van Dijk, J. H., Balleine, R. L., Huschtscha, L. I., Reddel, R. R., & Clarke, C. L. (2009) · Endocrinology · doi:10.1210/en.2008-1630 · Cited by 134
Neubauer, H. J., Clare, S. E., Woźny, W., Schwall, G., Poznanović, S., Stegmann, W., Vogel, U. F., Sotlar, K., Wallwiener, D. R., Kurek, R., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2155 · Cited by 131
Shyamala, G., Chou, Y.-C., Louie, S. G., Guzman, R. C., Smith, G. H., & Nandi, S. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00182-0 · Cited by 129
Endogenous Hormone Levels and Risk of Breast, Endometrial and Ovarian Cancers:
Eliasen, A., & Hankinson, S. E. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_10 · Cited by 125
Ismail, P. M., Amato, P., Soyal, S. M., DeMayo, F. J., Conneely, O. M., O’Malley, B. W., & Lydon, J. P. (2003) · Steroids · doi:10.1016/s0039-128x(03)00133-8 · Cited by 121
Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk
Rajaram, R. D., Buric, D., Čaikovski, M., Ayyanan, A., Rougemont, J., Shan, J., Vainio, S. J., Yalcin-Ozuysal, Ö., & Brisken, C. (2015) · The EMBO Journal · doi:10.15252/embj.201490434 · Cited by 119
Non-genomic mechanisms of progesterone action in the brain
Singh, M., Su, C., & Ng, S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00159 · Cited by 117
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
Nguyen, L. V., Pellacani, D., Lefort, S., Kannan, N., Osako, T., Makarem, M., Cox, C. L., Kennedy, W., Beer, P. A., Carles, A., et al. (2015) · Nature · doi:10.1038/nature15742 · Cited by 116
Self-citationProgesterone receptor membrane component 1—Many tasks for a versatile protein
Lösel, R., Besong, D., Peluso, J. J., & Wehling, M. (2007) · Steroids · doi:10.1016/j.steroids.2007.12.017 · Cited by 115
Wiebe, J. P., Muzia, D., Hu, J. J., Szwajcer, D., Hill, S. A., & Seachrist, J. L. (2000) · PubMed · Cited by 114
Tung, L. W., Abdel-Hafiz, H. A., Shen, T., Harvell, D. M. E., Nitao, L. K., Richer, J. K., Sartorius, C. A., Takimoto, G. S., & Horwitz, K. B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0105 · Cited by 112
Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells
Finlay-Schultz, J., & Sartorius, C. A. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9340-5 · Cited by 111
Structural and functional analysis of domains of the progesterone receptor
Hill, K. K., Roemer, S. C., Churchill, M. E. A., & Edwards, D. P. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.017 · Cited by 110
SAU, A. C., Lau, R., Cabrita, M. A., Nolan, E., Crooks, P. A., Visvader, J. E., & Pratt, M. A. C. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.003 · Cited by 109
Thomas, H., Key, T., Allen, D., Jw, M., Dowsett, M., Fentiman, I., & Wang, D. Y. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.183 · Cited by 108
Porch, J. V., Lee, I., Cook, N. R., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1020617415381 · Cited by 107
Aisemberg, J., Vercelli, C. A., Bariani, M. V., Billi, S. C., Wolfson, M. L., & Franchi, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056161 · Cited by 106
Progesterone metabolites in breast cancer
Wiebe, J. P. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01010 · Cited by 105
Terminal Duct Lobular Unit Involution of the Normal Breast: Implications for Breast Cancer Etiology
Figueroa, J. D., Pfeiffer, R. M., Patel, D., Linville, L. M., Brinton, L. A., Gierach, G. L., Yang, X. R., Papathomas, D., Visscher, D. W., Mies, C., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju286 · Cited by 104
Self-citationPlasma prolactin and breast cancer risk: a meta- analysis
Wang, M., Wu, X., Chai, F., Zhang, Y., & Jiang, J. (2016) · Scientific Reports · doi:10.1038/srep25998 · Cited by 104
Zbuk, K. M., & Anand, S. S. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.083774 · Cited by 103
Deciphering the Mammary Epithelial Cell Hierarchy
Stingl, J., Raouf, A., Eirew, P. D., & Eaves, C. J. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2983 · Cited by 102
Kannan, N., Nguyen, L. V., Makarem, M., Dong, Y., Shih, K., Eirew, P. D., Raouf, A., Emerman, J. T., & Eaves, C. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403813111 · Cited by 99
Self-citationWang, Y., Dong, J., Li, D., Lai, L., Siwko, S. K., Li, Y., & Liu, M. (2013) · Stem Cells · doi:10.1002/stem.1438 · Cited by 96
Diep, C. H., Ahrendt, H. D., & Lange, C. A. (2016) · Steroids · doi:10.1016/j.steroids.2016.09.004 · Cited by 95
Kaaks, R., Tikk, K., Sookthai, D., Schöck, H., Johnson, T., Tjønneland, A. M., Olsen, A., Overvad, K., Clavel‐Chapelon, F., Dossus, L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28528 · Cited by 92
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk
Brinton, L. A., Key, T., Kolonel, L. N., Michels, K. B., Sesso, H. D., Ursin, G., Eeden, S. K. V. D., Wood, S. N., Falk, R. T., Parisi, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1602 · Cited by 92
Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers
Truong, T. H., & Lange, C. A. (2018) · Endocrinology · doi:10.1210/en.2018-00831 · Cited by 84
Progestin and breast cancer risk: a systematic review
Samson, M. E., Porter, N. R., Orekoya, O., Hébert, J. R., Adams, S. A., Bennett, C. L., & Steck, S. E. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3663-1 · Cited by 83
Mukherjee, A., Soyal, S. M., Li, J., Yan, Y., He, B., DeMayo, F. J., & Lydon, J. P. (2010) · The FASEB Journal · doi:10.1096/fj.10-157982 · Cited by 82
Fortner, R. T., Eliassen, A. H., Spiegelman, D. L., Willett, W. C., Barbieri, R. L., & Hankinson, S. E. (2013) · Breast Cancer Research · doi:10.1186/bcr3394 · Cited by 82
Stem and progenitor cell division kinetics during postnatal mouse mammary gland development
Giraddi, R. R., Shehata, M., Gallardo, M., Blasco, M. A., Simons, B. D., & Stingl, J. (2015) · Nature Communications · doi:10.1038/ncomms9487 · Cited by 81
Dowsett, M., & Folkerd, E. J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3211-4 · Cited by 79
Antiprogestins in breast cancer treatment: are we ready?
Lanari, C., Wargon, V., Rojas, P., & Molinolo, A. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0378 · Cited by 79
Sisay, M., Mengistu, G., & Edessa, D. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s135867 · Cited by 79
Wolf, R. M., & Long, D. N. (2016) · Pediatrics in Review · doi:10.1542/pir.2015-0065 · Cited by 79
Reproductive functions of the progesterone receptor
Conneely, O. M., Lydon, J. P., Mayo, F. D., & O'Malley, B. W. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(99)00062-3 · Cited by 78
Neubauer, H. J., Adám, G., Seeger, H., Mueck, A. O., Solomayer, E., Wallwiener, D. R., Cahill, M. A., & Fehm, T. N. (2009) · Climacteric · doi:10.1080/13697130802635637 · Cited by 75
Progesterone Action in Normal Mouse Mammary Gland*
Wang, S., Counterman, L. J., & Haslam, S. Z. (1990) · Endocrinology · doi:10.1210/endo-127-5-2183 · Cited by 73
Fridriksdottir, A. J., Kim, J., Villadsen, R., Klitgaard, M. C., Hopkinson, B. M., Petersen, O. W., & Rønnov‐Jessen, L. (2015) · Nature Communications · doi:10.1038/ncomms9786 · Cited by 73
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
Singhal, H., Greene, M. E., Zarnke, A. L., Lainé, M., Abosy, R. A., Chang, Y.-F., Dembo, A. G., Schoenfelt, K. Q., Vadhi, R., Qiu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21378 · Cited by 73
Soini, T., Hurskainen, R., Grénman, S., Maenpaa, J. U., Paavonen, J. A., Joensuu, H., & Pukkala, E. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1062538 · Cited by 72
The intracrinology of breast cancer
McNamara, K. M., & Sasano, H. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.004 · Cited by 72
Progestins and Antiprogestins in Clinical Practice
Sitruk-Ware, L. R., & Mishell, D. R. (1999) · Medical Entomology and Zoology · Cited by 71
Strom, B. L., Berlin, J. A., Weber, A. L., Norman, S. A., Bernstein, L., Burkman, R. T., Daling, J. R., Deapen, D., Folger, S. G., Malone, K. E., et al. (2004) · Contraception · doi:10.1016/j.contraception.2003.12.015 · Cited by 71
Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
Palomba, S., Santagni, S., & Sala, G. B. L. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0205-8 · Cited by 70
Widschwendter, M., Burnell, M., Fraser, L. S. M., Rosenthal, A. N., Philpott, S., Reisel, D., Dubeau, L., Cline, M., Pan, Y., Yi, P.-C., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.037 · Cited by 69
Pardo, I., Lillemoe, H. A., Blosser, R. J., Choi, M.-R., Sauder, C. A. M., Doxey, D. K., Mathieson, T., Hancock, B. A., Baptiste, D. F., Atale, R. V., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3627 · Cited by 68
Lee, H. J., & Ormandy, C. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.020 · Cited by 67
Figueroa, J. D., Pfeiffer, R. M., Brinton, L. A., Palakal, M. M., Degnim, A. C., Radisky, D. C., Hartmann, L. C., Frost, M. H., Stallings‐Mann, M. L., Papathomas, D., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3908-7 · Cited by 65
Self-citationCalle, E. E., Feigelson, H. S., Hildebrand, J. S., Teras, L. R., Thun, M. J., & Rodríguez, C. (2009) · Cancer · doi:10.1002/cncr.24101 · Cited by 64
Steroid-Protein Interactions Revisited
Westphal, U. (1986) · Monographs on endocrinology · doi:10.1007/978-3-642-82486-9_1 · Cited by 63
Factors Related to Declining Luteal Function in Women during the Menopausal Transition
Santoro, N., Crawford, S. L., Lasley, W. L., Luborsky, J. L., Matthews, K. A., McConnell, D. S., Randolph, J. F., Gold, E. B., Greendale, G. A., Korenman, S. G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2165 · Cited by 63
Mechanism of the mitogenic influence of hyperinsulinemia
Draznin, B. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-10 · Cited by 63
Kannan, N., Huda, N., Tu, L., Droumeva, R., Aubert, G., Chavez, E. A., Brinkman, R. R., Lansdorp, P. M., Emerman, J. T., Abe, S., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.04.003 · Cited by 62
Self-citationOsteoprotegerin in breast cancer: beyond bone remodeling
Weichhaus, M., Chung, S. T. M., & Connelly, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0390-5 · Cited by 60
Progesterone action and responses in the αERKO mouse
Hewitt, S. C., & Korach, K. S. (2000) · Steroids · doi:10.1016/s0039-128x(00)00113-6 · Cited by 58
Progesterone regulation of stem and progenitor cells in normal and malignant breast
Axlund, S. D., & Sartorius, C. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.021 · Cited by 57
Schuster, J., Karlsson, T., Karlström, P., Poromaa, I. S., & Dahl, N. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-58 · Cited by 55
Telomere fusions in early human breast carcinoma
Tanaka, H., Abe, S., Huda, N., Tu, L., Beam, M. J., Grimes, B., & Gilley, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120062109 · Cited by 52
Unraveling the human progesterone receptor signal transduction pathway
McDonnell, D. P. (1995) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)00065-p · Cited by 52
Stem Cells and the Developing Mammary Gland
Makarem, M., Spike, B. T., Dravis, C., Kannan, N., Wahl, G. M., & Eaves, C. J. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9284-6 · Cited by 49
Self-citationWiebe, J. P., Zhang, G., Welch, I. D., & Cadieux-Pitre, H.-A. T. (2013) · Breast Cancer Research · doi:10.1186/bcr3422 · Cited by 46
Neubauer, H. J., Yang, Y., Seeger, H., Fehm, T. N., Cahill, M. A., Tong, X., Ruan, X., & Mueck, A. O. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31820e5ac5 · Cited by 45
Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort
Schernhammer, E. S., Sperati, F., Razavi, P., Agnoli, C., Sieri, S., Berrino, F., Krogh, V., Abbagnato, C. A., Grioni, S., Blandino, G., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3438 · Cited by 42
Reproductive Functions of the Progesterone Receptor
Conneely, O. M., Lydon, J. P., Mayo, F. J. D., & O’Malley, B. W. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1177/1071557600007001s09 · Cited by 42
Labrie, F. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.012 · Cited by 40
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
Odén, L., Akbari, M. R., Zaman, T., Singer, C. F., Sun, P., Narod, S. A., Salmena, L., & Kotsopoulos, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13417 · Cited by 40
New concepts of breast cell communication to bone
Horseman, N. D., & Hernandez, L. L. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.08.004 · Cited by 39
The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells
Alférez, D., Simões, B. M., Howell, S. J., & Clarke, R. B. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0114-z · Cited by 38
Hormonal contraception and breast cancer
Westhoff, C. L., & Pike, M. C. (2018) · Contraception · doi:10.1016/j.contraception.2018.05.002 · Cited by 38
Alternative 5′-untranslated first exons of the mouse Cyp19A1 (aromatase) gene
Chow, J. D. Y., Simpson, E. R., & Boon, W. C. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.03.010 · Cited by 36
Stanczyk, F. Z., Azen, C. G., & Pike, M. C. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.015 · Cited by 36
Self-citationDiep, C. H., Knutson, T. P., & Lange, C. A. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0431 · Cited by 36
Overexpression of progesterone receptor membrane component 1
Neubauer, H. J., Ruan, X., Schneck, H., Seeger, H., Cahill, M. A., Liang, Y., Mafuvadze, B., Hyder, S. M., Fehm, T. N., & Mueck, A. O. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182755c97 · Cited by 35
Bringing androgens up a NOTCH in breast cancer
Tarulli, G. A., Butler, L. M., Tilley, W. D., & Hickey, T. E. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0248 · Cited by 35
Cordero, Á., Pellegrini, P., Sanz‐Moreno, A., Trinidad, E. M., Serra-Musach, J., Deshpande, C., Dougall, W. C., Pujana, M. Á., & González‐Suárez, E. (2015) · Stem Cells · doi:10.1002/stem.2271 · Cited by 35
Stanczyk, F. Z. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182260321 · Cited by 32
Self-citationBiological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer
Lamb, C. A., Fabris, V. T., Jacobsen, B. M., Molinolo, A., & Lanari, C. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0179 · Cited by 32
Haslam, S. Z., Drolet, A., Smith, K. T., Tan, M., & Aupperlee, M. D. (2008) · Endocrinology · doi:10.1210/en.2007-1398 · Cited by 31
Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
Khodr, Z. G., Sherman, M. E., Pfeiffer, R. M., Gierach, G. L., Brinton, L. A., Falk, R. T., Patel, D. A., Linville, L. M., Papathomas, D., Clare, S. E., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0667 · Cited by 31
Self-citationFortner, R. T., Sarink, D., Schöck, H., Johnson, T., Tjønneland, A. M., Olsen, A., Overvad, K., Affret, A., His, M., Boutron‐Ruault, M., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0786-8 · Cited by 30
Werner, S., Kunz, S., Beckurts, T., et al. (1997) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(97)00167-8 · Cited by 27
Miller, M. M., James, R. A., Richer, J. K., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4239 · Cited by 27
Perlman, B., Kulak, D., Goldsmith, L. T., & Weiss, G. (2018) · Global Reproductive Health · doi:10.1097/grh.0000000000000008 · Cited by 25
Isoform specificity of progesterone receptor antibodies
Fabris, V. T., Abascal, M. F., Giulianelli, S., May, M., Sequeira, G. R., Jacobsen, B. M., Lombès, M., Han, J., Tran, L. H., Molinolo, A., et al. (2017) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.83 · Cited by 20
BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells
He, Z., Kannan, N., Nemirovsky, O., Chen, H., Connell, M., Taylor, B., Jiang, J., Pilarski, L. M., Fleisch, M. C., Niederacher, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15688 · Cited by 19
Self-citationTrabert, B. L., Falk, R. T., Stanczyk, F. Z., McGlynn, K. A., Brinton, L. A., & Xu, X. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0026 · Cited by 17
Self-citationMacrophages stimulate mammary stem cells
Kannan, N., & Eaves, C. J. (2018) · Science · doi:10.1126/science.aau1394 · Cited by 10
Self-citation
Cited by
Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy
Viuff, M. H., Stochholm, K., Lin, A., Berglund, A., Juul, S., & Gravholt, C. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0702 · Cited by 46
Metadata
- Authors
- Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-05-02
- Volume
- 41
- Issue
- 2
- Pages
- 320-344
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2973077025
- Cited by
- 271
- References
- 192
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.